Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial
Fabio Piscaglia, Gianluca Masi, Erika Martinelli, et al.
ESMO Open (2025) Vol. 10, Iss. 2, pp. 104110-104110
Closed Access | Times Cited: 3

Showing 3 citing articles:

What can real-world data teach us about treating patients with unresectable hepatocellular carcinoma?
Andrea Dalbeni, Filippo Cattazzo, L.A. Natola, et al.
Expert Review of Gastroenterology & Hepatology (2025), pp. 1-10
Closed Access
Response to: Atezolizumab plus bevacizumab in unresectable HCC: insights from the AMETHISTA trial interim analysis
L. Rimassa, C. Astolfi, Fabio Piscaglia
ESMO Open (2025) Vol. 10, Iss. 4, pp. 104547-104547
Open Access
Comment on: Atezolizumab plus bevacizumab in unresectable HCC: insights from the AMETHISTA trial interim analysis
Wenfeng Zhu, Chao Fan, Jing Qin, et al.
ESMO Open (2025) Vol. 10, Iss. 4, pp. 104546-104546
Open Access
The present and the future of immunotherapy in hepatocellular carcinoma and biliary tract cancers
Giuseppe Cabibbo, Lorenza Rimassa, Ángela Lamarca, et al.
Cancer Treatment Reviews (2025), pp. 102955-102955
Open Access
Page 1

Scroll to top